Sulotrim 200 mg + 40 mg/5 ml oralna suspenzija Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sulotrim 200 mg + 40 mg/5 ml oralna suspenzija

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - sulfamethoxazolum, trimethoprimum - oralna suspenzija - 200 mg + 40 mg/5 ml - urbroj: 5 ml oralne suspenzije sadrži 200 mg sulfametoksazola i 40 mg trimetoprima

DEPRIM 400 mg/1 tableta+ 80 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

deprim 400 mg/1 tableta+ 80 mg/1 tableta tableta

farmalogist allbix d.o.o. bijeljina - sulfametoksazol, trimetoprim - tableta - 400 mg/1 tableta+ 80 mg/1 tableta - 1 tableta sadrži: 400 mg sulfametoksazola i 80 mg trimetoprima

ESBESUL 400 mg/1 tableta+ 80 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

esbesul 400 mg/1 tableta+ 80 mg/1 tableta tableta

bosnalijek d.d. - sulfametoksazol, trimetoprim - tableta - 400 mg/1 tableta+ 80 mg/1 tableta - 1 tableta sadrži: 400 mg sulfametoksazol 80 mg trimetoprim

Sulotrim 100 mg + 20 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sulotrim 100 mg + 20 mg tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - sulfametoksazol trimetoprim - tableta - 100 mg + 20 mg - urbroj: jedna tableta sadrži 100 mg sulfametoksazola i 20 mg trimetoprima

Sulotrim 400 mg + 80 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sulotrim 400 mg + 80 mg tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - sulfametoksazol trimetoprim - tableta - 400 mg + 80 mg - urbroj: jedna tableta sadrži 400 mg sulfametoksazola i 80 mg trimetoprima

Sulotrim forte 800 mg + 160 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sulotrim forte 800 mg + 160 mg tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - sulfametoksazol trimetoprim - tableta - 800 mg + 160 mg - urbroj: jedna tableta sadrži 800 mg sulfametoksazola i 160 mg trimetoprima

Qaialdo Europska Unija - hrvatski - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 i 5.

ESBESUL 200 mg/5 mL+ 40 mg/5 mL sirup Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

esbesul 200 mg/5 ml+ 40 mg/5 ml sirup

bosnalijek d.d. - sulfametoksazol, trimetoprim - sirup - 200 mg/5 ml+ 40 mg/5 ml - 5 ml sirupa sadrži: 200 mg sulfametoksazola 40 mg trimetoprima

ESBESUL 400 mg/1 tableta+ 80 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

esbesul 400 mg/1 tableta+ 80 mg/1 tableta tableta

bosnalijek d.d. - sulfametoksazol, trimetoprim - tableta - 400 mg/1 tableta+ 80 mg/1 tableta - 1 tableta sadrži: 400 mg sulfametoksazol 80 mg trimetoprim

Jayempi Europska Unija - hrvatski - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - odbacivanje transplantata - imunosupresivi - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.